Clinical
RSSArticles
-
More Promise from Olaparib in Recurrent Ovarian Cancer: The BRCA Cohort
Olaparib, a poly (ADP)-ribose polymerase (PARP) inhibitor, demonstrated substantial delay until progression when administered to women as a maintenance therapy with BRCA-mutant recurrent ovarian cancer. -
AMH: Marker of Ovarian Reserve and More
Serum anti-Mullerian hormone (AMH) has been well-established as an accurate marker of ovarian reserve. It is solely produced in the human ovary by the granulosa cells. -
Do Patients Need Routine Pelvic Exams?
A review of the published literature finds no value to the routine screening pelvic examination in asymptomatic non-pregnant women. -
Medical Treatment Is Effective, But Only if It is Used
In this randomized controlled trial, those sleep apnea patients who received a brief (< 1 hour, total) motivational education program had substantially better continuous positive airway pressure adherence in a short-term follow-up. -
Reader Comment
-
Clinical Briefs: Cataract and Antioxidants
La Puma J. Cataract and antioxidants. Altern Med Alert 2002;5:24. -
Clinical Briefs: Age-Related Macular Degeneration and Antioxidants
La Puma J. Age-related macular degeneration and antioxidants. Altern Med Alert 2002;5:23-24. -
Inositol as a Cholesterol-Lowering Agent
Ramalanjaona G. Inositol as a cholesterol-lowering agent. Altern Med Alert 2002;5:16-18. -
Acupuncture for Fibromyalgia
Assefi N. Acupuncture for fibromyalgia. Altern Med Alert 2002;5:13-16. -
STD Quarterly: Get latest STD stats from CDC web site